Benzinga's Top Downgrades - Best Buy Co (NYSE:BBY)

Analysts at Morgan Stanley downgraded

Best Buy Co IncBBY

from Overweight to Equal-weight. Best Buy shares closed at $27.11 on Friday. Analysts at Barclays downgraded

ResMed Inc. RMD

from Equal-weight to Underweight. The price target ResMed has been lowered from $61 to $52. ResMed shares closed at $53.29 on Friday. RBC Capital downgraded

Sarepta Therapeutics Inc SRPT

from Outperform to Sector Perform. Sarepta Therapeutics shares closed at $14.28 on Friday. Analysts at JP Morgan downgraded

McCormick & Company, IncorporatedMKC

from Neutral to Underweight. The price target McCormick has been lowered from $82 to $76. McCormick shares closed at $83.71 on Friday. Analysts at William Blair downgraded

Dunkin Brands Group IncDNKN

to Market Perform. Dunkin Brands shares closed at $37.86 on Friday. Stifel Nicolaus downgraded

MSG Networks Inc MSGN

from Hold to Sell. MSG Networks shares closed at $19.50 on Friday. JMP Securities downgraded

UDR, Inc. UDR

from Outperform to Market Perform. UDR shares closed at $35.78 on Friday. Deutsche Bank downgraded

Smith & Nephew plc (ADR) SNN

from Buy to Hold. Smith & Nephew shares closed at $31.85 on Friday. Analysts at Monness Crespi Hardt downgraded

Methanex Corporation (USA) MEOH

from Buy to Neutral. Methanex shares closed at $25.48 on Friday. Analysts at Bernstein downgraded

Progressive CorpPGR

from Outperform to Market Perform. Progressive shares closed at $29.91 on Friday.

Market News and Data brought to you by Benzinga APIs